Vanda And The $1 Billion Question With Fanapt
Will Vanda's Fanapt sales be as huge as some analysts suggest?
Biotechs Selling For Less Than Net Cash
It is possible to buy shares of a drug developer for less than the value of the cash on its balance sheet
Transcript of Dendreon at BIO Conference
Read what Dendreon's CEO had to say about Provenge's manufacturing process and the future.
Transcript of PDL BioPharma at BIO Conference
Read what PDL's CEO had to say about patent issues, dividend plans, and the future
Vanda Fanapt FDA Approval Conference Call Transcript
Vanda Pharmaceuticals cc transcript discussing the FDA approval of its antipsychotic drug Fanapt
Dendreon IMPACT Results Conference Call Transcript
Transcript of Dendreon's April 28 conference call at the American Urological Assocation meeting
Take That Subset Analysis And Shove It
Why you should approach certain retrospective analyses with extreme caution
Daily Stock Price Δ
| NASDAQ | 2816.55 | |||||||
| S&P 500 | 1316.33 | |||||||
| AMGN | 68.34 | |||||||
| GENZ | 0.00 | |||||||
| GILD | 48.72 | |||||||
| BIIB | 118.56 | |||||||
| PFE | 21.48 | |||||||
| MRK | 38.52 | |||||||
| GSK | 44.87 | |||||||
| NVS | 54.41 | |||||||
| RHHBY.PK | 43.12 | |||||||
| BAY.DE | 0.00 | |||||||
| ^BTK | 1309.24 | |||||||
| ^NBI | 1203.40 | |||||||
| ARQL | 7.47 | |||||||
| SNY | 36.96 | |||||||
| VRUS | 0.00 | |||||||